Local anaesthetic medication for the treatment of asthma.
It is presumed that drugs able to prevent bronchial spasm and/or inflammation may have therapeutic potential to control asthma symptoms. The local anaesthetic lidocaine has recently received increased attention as an alternative form of treatment for asthmatic patients. This paper reviews the major findings on the topic and summarizes the putative mechanisms underlying the airway effects of local anaesthetic agents. We think that lidocaine extends the spectrum of options in asthma therapy, probably by counteracting both spasmogenic and inflammatory stimuli in the bronchial airways. The possibility of development of new anti-asthma compounds based on the synthesis of lidocaine derivatives is also on the horizon.
Siqueira
Rodrigo A
RA
Laboratório de Inflamação, Departamento de Fisiologia e Farmacodinâmica, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ 21040-900, Brasil.
Costa
Jorge C S
JC
Cordeiro
Renato S B
RS
Serra
Magda F
MF
e Silva
Patrícia M R
PM
Martins
Marco A
MA
D000779:Anesthetics, Local / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*
D000779:Anesthetics, Local; D018927:Anti-Asthmatic Agents; D008012:Lidocaine